Ce4less.com

Recommend the use of subcutaneous low-dose low molecular weight heparin (LMWH) to prevent DVT/ PE for patients with ischemic stroke or hemorrhagic stroke and leg weakness with impaired mobility. Attention to a history of heparin-induced thrombocytopenia will affect treatment choice. ................
................